SWP
SLS icon

Strategic Wealth Partners’s SELLAS Life Sciences SLS Stock Holding History

Strategic Wealth Partners’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21K Hold
150
– – ﹤0.01% 1181
2026
Q1 		$635 Buy
+150
New +$671 ﹤0.01% 1298

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Strategic Wealth Partners's SLS Position: Q2 2026 in Review

Strategic Wealth Partners held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 150 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

Strategic Wealth Partners first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Strategic Wealth Partners held 150 shares of SELLAS Life Sciences worth $2.21K as of Q2 2026.
  • Strategic Wealth Partners left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #1181 holding.
  • Strategic Wealth Partners first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.